Literature DB >> 9126804

Transforming growth factor-beta gene expression in normal and fibrotic rat liver.

P J De Bleser1, T Niki, V Rogiers, A Geerts.   

Abstract

BACKGROUND/AIMS: Transforming growth factor-beta (TGF-beta) is considered to be an important mediator in the development of fibrosis in several chronic liver diseases. To understand the mechanism(s) by which TGF-beta exerts its action(s), we investigated the cellular distribution of TGF-beta(1,2,3) transcripts in normal and carbon tetrachloride (CCl4)-induced fibrotic rat liver.
METHODS: Parenchymal, sinusoidal endothelial, Kupffer and stellate cells were isolated and purified. The exact cellular composition of each isolate was determined by transmission electron microscopy. Expression of TGF-beta(1,2,3) transcripts was investigated using Northern hybridization analysis. Hybridization signals were quantified by scanning densitometry and corrected for: (i) differences in extractable RNA per cell type, (ii) signal contribution from contaminating cells, and (iii) differences in loading, capillary transfer and hybridization.
RESULTS: In normal liver, TGF-beta1 mRNA was predominantly expressed in Kupffer cells, exhibiting values approximately 9-fold higher than those in stellate cells. No expression was found in endothelial and parenchymal cells. Signals for TGF-beta2 and TGF-beta3 were much weaker when compared to TGF-beta1. In Kupffer cells, the level of TGF-beta2 was approximately 4-fold higher than in stellate cells. Little expression was found in endothelial cells. TGF-beta3 expression could only be detected in stellate cells. TGF-beta2 and TGF-beta3 was not expressed in parenchymal cells. In fibrotic liver, TGF-beta1 mRNA was strongly expressed in all the sinusoidal cells. TGF-beta2 and TGF-beta3 could no longer be detected. When compared to the level of expression in normal stellate cells, the level of TGF-beta1 increased 12-fold in stellate cells from fibrotic livers, and 6-fold in endothelial cells. In Kupffer cells, the level of expression remained unchanged.
CONCLUSIONS: (i) In both normal and fibrotic liver, TGF-beta1 is the most abundant isoform, (ii) in normal liver, TGF-beta1 is expressed strongly by Kupffer cells and moderately by stellate cells, TGF-beta2 expression is highest in Kupffer cells, followed by stellate cells and endothelial cells. TGF-beta3 is expressed by stellate cells, (iii) in fibrotic liver, the level of TGF-beta1 expression increases selectively in stellate cells and endothelial cells. This suggests an important role, not only for stellate, but also for endothelial cells in fibrogenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9126804     DOI: 10.1016/s0168-8278(97)80257-7

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  48 in total

1.  Platelet-derived growth factor is a principal inductive factormodulating mannose 6-phosphate/insulin-like growth factor-II receptorgene expression via a distal E-box in activated hepatic stellate cells.

Authors:  J A Weiner; A Chen; B H Davis
Journal:  Biochem J       Date:  2000-01-15       Impact factor: 3.857

Review 2.  Advances in gene therapy of liver cirrhosis: a review.

Authors:  W J Dai; H C Jiang
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

3.  Dynamic changes of type I,III and IV collagen synthesis and distribution of collagen-producing cells in carbon tetrachloride-induced rat liver fibrosis.

Authors:  Wei-Dong Du; Yue-E Zhang; Wei-Rong Zhai; Xiao-Mei Zhou
Journal:  World J Gastroenterol       Date:  1999-10       Impact factor: 5.742

4.  Effects of retinoic acid on proliferation, phenotype and expression of cyclin-dependent kinase inhibitors in TGF-beta1-stimulated rat hepatic stellate cells.

Authors:  Guang-Cun Huang; Jin-Sheng Zhang; Yue-E Zhang
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

Review 5.  Immunomodulatory effects of transforming growth factor-β in the liver.

Authors:  Hans-Theo Schon; Ralf Weiskirchen
Journal:  Hepatobiliary Surg Nutr       Date:  2014-12       Impact factor: 7.293

6.  Serum transforming growth factor beta 3 predicts future development of nonalcoholic fatty liver disease.

Authors:  Yongli Wei; Qing Tian; Xiuxia Zhao; Xingchun Wang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

7.  Effect of losartan, an angiotensin II antagonist, on hepatic fibrosis induced by CCl4 in rats.

Authors:  Yao Hong Wei; Li Jun; Chen Ji Qiang
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

8.  Activation of PPARgamma is required for curcumin to induce apoptosis and to inhibit the expression of extracellular matrix genes in hepatic stellate cells in vitro.

Authors:  Shizhong Zheng; Anping Chen
Journal:  Biochem J       Date:  2004-11-15       Impact factor: 3.857

9.  Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells.

Authors:  Anping Chen
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

Review 10.  Oxidative and nitrosative stress and fibrogenic response.

Authors:  R Urtasun; L Conde de la Rosa; N Nieto
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.